ReviewBiomedicines2023

Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges.

Krisida Cerma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.